What is Viropil (TLD Regimen)?
Viropil is a potent, fixed-dose combination antiretroviral medication used in the management of HIV-1 infection. It combines three powerful drugs—Dolutegravir (50mg), Lamivudine (300mg), and Tenofovir Disoproxil Fumarate (300mg)—into a single, once-daily tablet. This specific combination is widely known as the TLD regimen and is recommended as a first-line treatment for adults and adolescents by both Nigerian health authorities and the World Health Organization (WHO).
How Viropil Works
Viropil works by targeting the HIV virus at different stages of its life cycle. Dolutegravir is an integrase inhibitor that prevents the virus from inserting its DNA into healthy cells. Lamivudine and Tenofovir are reverse transcriptase inhibitors that block the virus from replicating. Together, they help reduce the viral load in the body to undetectable levels, allowing the immune system to recover and reducing the risk of transmitting the virus to others.
Benefits of Viropil
- Simple Dosage: One pill a day simplifies your treatment routine and improves adherence.
- High Viral Suppression: Helps achieve and maintain a low viral load quickly.
- Resistance Management: The triple-drug combination makes it harder for the virus to develop resistance.
- Well-Tolerated: Formulated to provide effective treatment with manageable side effects.
Usage and Safety Information
Viropil should be taken consistently at the same time every day. It is important not to skip doses to ensure the medication remains effective. Common side effects include mild headaches or difficulty sleeping (insomnia), which often improve as your body adjusts.
Note: Always consult with a healthcare professional before starting or changing your ART regimen. You can contact a GoMed pharmacist for guidance on your medication and delivery options across Nigeria.